Advancement in biomarker based effective diagnosis of neonatal sepsis

AbstractNeonatal sepsis is considered as alarming medical emergency and becomes the common global reason of neonatal mortality. Non-specific symptoms and limitations of conventional diagnostic methods for neonatal sepsis mandate fast and reliable method to diagnose disease for point of care applicat...

Full description

Bibliographic Details
Main Authors: Neha Gopal, Nidhi Chauhan, Utkarsh Jain, Sujata K. Dass, Hari S. Sharma, Ramesh Chandra
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Artificial Cells, Nanomedicine, and Biotechnology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21691401.2023.2252016
_version_ 1797631166979768320
author Neha Gopal
Nidhi Chauhan
Utkarsh Jain
Sujata K. Dass
Hari S. Sharma
Ramesh Chandra
author_facet Neha Gopal
Nidhi Chauhan
Utkarsh Jain
Sujata K. Dass
Hari S. Sharma
Ramesh Chandra
author_sort Neha Gopal
collection DOAJ
description AbstractNeonatal sepsis is considered as alarming medical emergency and becomes the common global reason of neonatal mortality. Non-specific symptoms and limitations of conventional diagnostic methods for neonatal sepsis mandate fast and reliable method to diagnose disease for point of care application. Recently, disease specific biomarkers have gained interest for rapid diagnosis that led to the development of electrochemical biosensor with enhanced specificity, sensitivity, cost-effectiveness and user-friendliness. Other than conventional biomarker C-reactive protein to diagnose neonatal sepsis, several potential biomarkers including Procalcitonin (PCT), Serum amyloid A (SAA) and other candidates are extensively investigated. The present review provides insights on advancements and diagnostic abilities of protein and nucleotide based biomarkers with their incorporation in developing electrochemical biosensors by employing novel fabrication strategies. This review provides an overview of most promising biomarker and its capability for neonatal sepsis diagnosis to fulfil future demand to develop electrochemical biosensor for point-of-care applications.
first_indexed 2024-03-11T11:17:09Z
format Article
id doaj.art-1273106582664bdeae59ab0ac4997cdd
institution Directory Open Access Journal
issn 2169-1401
2169-141X
language English
last_indexed 2024-03-11T11:17:09Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Artificial Cells, Nanomedicine, and Biotechnology
spelling doaj.art-1273106582664bdeae59ab0ac4997cdd2023-11-10T17:19:33ZengTaylor & Francis GroupArtificial Cells, Nanomedicine, and Biotechnology2169-14012169-141X2023-12-0151147649010.1080/21691401.2023.2252016Advancement in biomarker based effective diagnosis of neonatal sepsisNeha Gopal0Nidhi Chauhan1Utkarsh Jain2Sujata K. Dass3Hari S. Sharma4Ramesh Chandra5Department of Chemistry, University of Delhi, Delhi, IndiaAmity Institute of Nanotechnology, Amity University, Noida, Uttar Pradesh, IndiaAmity Institute of Nanotechnology, Amity University, Noida, Uttar Pradesh, IndiaDepartment of Neurology, BLK Super Speciality Hospital, New Delhi, IndiaDepartment of Pathology and Clinical Bioinformatics, Erasmus MC, University Medical Center, Rotterdam, The NetherlandsDepartment of Chemistry, University of Delhi, Delhi, IndiaAbstractNeonatal sepsis is considered as alarming medical emergency and becomes the common global reason of neonatal mortality. Non-specific symptoms and limitations of conventional diagnostic methods for neonatal sepsis mandate fast and reliable method to diagnose disease for point of care application. Recently, disease specific biomarkers have gained interest for rapid diagnosis that led to the development of electrochemical biosensor with enhanced specificity, sensitivity, cost-effectiveness and user-friendliness. Other than conventional biomarker C-reactive protein to diagnose neonatal sepsis, several potential biomarkers including Procalcitonin (PCT), Serum amyloid A (SAA) and other candidates are extensively investigated. The present review provides insights on advancements and diagnostic abilities of protein and nucleotide based biomarkers with their incorporation in developing electrochemical biosensors by employing novel fabrication strategies. This review provides an overview of most promising biomarker and its capability for neonatal sepsis diagnosis to fulfil future demand to develop electrochemical biosensor for point-of-care applications.https://www.tandfonline.com/doi/10.1080/21691401.2023.2252016Neonatal sepsisbiomarkernanomaterialselectrochemical biosensordiagnosis
spellingShingle Neha Gopal
Nidhi Chauhan
Utkarsh Jain
Sujata K. Dass
Hari S. Sharma
Ramesh Chandra
Advancement in biomarker based effective diagnosis of neonatal sepsis
Artificial Cells, Nanomedicine, and Biotechnology
Neonatal sepsis
biomarker
nanomaterials
electrochemical biosensor
diagnosis
title Advancement in biomarker based effective diagnosis of neonatal sepsis
title_full Advancement in biomarker based effective diagnosis of neonatal sepsis
title_fullStr Advancement in biomarker based effective diagnosis of neonatal sepsis
title_full_unstemmed Advancement in biomarker based effective diagnosis of neonatal sepsis
title_short Advancement in biomarker based effective diagnosis of neonatal sepsis
title_sort advancement in biomarker based effective diagnosis of neonatal sepsis
topic Neonatal sepsis
biomarker
nanomaterials
electrochemical biosensor
diagnosis
url https://www.tandfonline.com/doi/10.1080/21691401.2023.2252016
work_keys_str_mv AT nehagopal advancementinbiomarkerbasedeffectivediagnosisofneonatalsepsis
AT nidhichauhan advancementinbiomarkerbasedeffectivediagnosisofneonatalsepsis
AT utkarshjain advancementinbiomarkerbasedeffectivediagnosisofneonatalsepsis
AT sujatakdass advancementinbiomarkerbasedeffectivediagnosisofneonatalsepsis
AT harissharma advancementinbiomarkerbasedeffectivediagnosisofneonatalsepsis
AT rameshchandra advancementinbiomarkerbasedeffectivediagnosisofneonatalsepsis